In this work, we showed in silico that α5-PAM therapeutic doses, which effectively recover cortical microcircuit EEG, spiking activity and function, can be predicted from simulated EEG biomarkers of depression severity in terms of reduced SST interneuron inhibition. This evidence concerns the gene SST and depressive symptom measurement.